MicroMedTec closes multi-million-yuan Series Pre A by CDBI Partners

MicroMedTec has completed a Pre-A financing round of tens of millions of yuan, exclusively invested by CDBI Partners. The proceeds will be used to advance the company’s aneurysm interventional product, MeshCoil Dense network occluder, into clinical research.

MicroMedTec has completed a Pre-A financing round of tens of millions of yuan, exclusively invested by CDBI Partners. The proceeds will be used to advance the company’s aneurysm interventional product, MeshCoil Dense network occluder, into clinical research.

Established in 2014, MicroMedTec is a developer of surgical devices designed to treat cerebrovascular disease. The company’s products, including MeshCoil Dense network occluder, enable doctors to effectively treat cerebrovascular diseases, such as stroke, offering affordable and quick treatments to patients.

The founding team of MicroMedTec includes senior engineering technicians and clinical experts from China and abroad.

The founder and CEO Xiang Yonggang has 15 years of experience in the minimally invasive interventional medical device industry. He has successively served as a senior R&D engineer and R&D director of a well-known medical device company, and successfully developed several leading minimally invasive interventional treatment devices and introduced to the market.

He has obtained more than 50 invention patents, of which several patents have been authorized by the European Patent Office.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/06/micromedtec-closes-multi-million-yuan-series-pre-a-by-cdbi-partners/.

Leave a Reply

Please Login to Comment